@article{f6949b617c894916a7f3b5a4996d1f5f,
title = "Early life affects late-life health through determining DNA methylation across the lifespan: A twin study",
abstract = "Background: Previous findings for the genetic and environmental contributions to DNA methylation variation were for limited age ranges only. We investigated the lifespan contributions and their implications for human health for the first time. Methods: 1,720 monozygotic twin (MZ) pairs and 1,107 dizygotic twin (DZ) pairs aged 0-92 years were included. Familial correlations (i.e., correlations between twins) for 353,681 methylation sites were estimated and modelled as a function of twin pair cohabitation history. Findings: The methylome average familial correlation was around zero at birth (MZ pair: -0.01; DZ pair: -0.04), increased with the time of twins living together during childhood at rates of 0.16 (95\%CI: 0.12-0.20) for MZ pairs and 0.13 (95\%CI: 0.07-0.20) for DZ pairs per decade, and decreased with the time of living apart during adulthood at rates of 0.026 (95\%CI: 0.019-0.033) for MZ pairs and 0.027 (95\%CI: 0.011-0.043) for DZ pairs per decade. Neither the increasing nor decreasing rate differed by zygosity (both P>0.1), consistent with cohabitation environment shared by twins, rather than genetic factors, influencing the methylation familial correlation changes. Familial correlations for 6.6\% (23,386/353,681) sites changed with twin pair cohabitation history. These sites were enriched for high heritability, proximal promoters, and epigenetic/genetic associations with various early-life factors and late-life health conditions. Interpretation: Early life strongly influences DNA methylation variation across the lifespan, and the effects are stronger for heritable sites and sites biologically relevant to the regulation of gene expression. Early life could affect late-life health through influencing DNA methylation. Funding: Victorian Cancer Agency, Cancer Australia, Cure Cancer Foundation.",
keywords = "DNA methylation, DOHaD hypothesis, Heritability, Twin study",
author = "Shuai Li and Zhoufeng Ye and Mather, \{Karen A.\} and Nguyen, \{Tuong L.\} and Dite, \{Gillian S.\} and Armstrong, \{Nicola J.\} and Wong, \{Ee Ming\} and Anbupalam Thalamuthu and Giles, \{Graham G.\} and Craig, \{Jeffrey M.\} and Richard Saffery and Southey, \{Melissa C.\} and Qihua Tan and Sachdev, \{Perminder S.\} and Hopper, \{John L.\}",
note = "Funding Information: SL \& JLH were involved in study conception and design. SL and YZ analysed the data. SL and JLH drafted the first version of the manuscript. Data collection: PETS?SL, EMW, JMC, RS, MCS and JLH, AMDTSS?SL, EMW, TLN, GSD, GGG, MCS and JLH, OATS?NJA, KAM, PSS and AT, DTR and LSADT?QT. All authors participated manuscript revision and approved the final manuscript. SL has verified the data used in the analysis. This work was supported by grant ECRF19020 from the Victorian Cancer Agency, and by grant 1187896 awarded through the 2019 Priority-driven Collaborative Cancer Research Scheme and funded by Cure Cancer with the support of Cancer Australia. SL is a Victorian Cancer Agency Early Career Research Fellow (ECRF19020). SL and TLN were supported by the Cancer Council Victoria Postdoctoral Research Fellowship and the Picchi Award from the Victorian Comprehensive Cancer Centre. TLN was supported by the Cure Cancer Australia (APP1159399), and received a Grants-in-Aid grant from the Cancer Council Victoria (AF7305). MCS is a National Health and Medical Research Council (NHMRC) Senior Research Fellow (APP1155163). JLH is a NHMRC Senior Principal Research Fellow. The PETS was supported by grants from the NHMRC (Grant No. 1146333 to JC). The AMDTSS was facilitated through access to Twins Research Australia, a national resource supported by a Centre of Research Excellence Grant (Grant No. 1079102) from the NHMRC. The AMDTSS was supported by NHMRC (Grant Nos. 1050561 and 1079102), Cancer Australia and National Breast Cancer Foundation (Grant No. 509307). The OATS was funded by a NHMRC and Australian Research Council (ARC) Strategic Award Grant of the Ageing Well, Ageing Productively Program (Grant No. 401162) and NHMRC Project Grants (Grant Nos. 1045325 and 1085606). The OATS was facilitated through Twins Research Australia, a national resource in part supported by a Centre for Research Excellence Grant (Grant No. 1079102) from the NHMRC. We thank the participants of all studies. The PETS thanks all of the supportive families who participated in the PETS study throughout the years, and research staff, volunteers, and the phlebotomists from Royal Children's Hospital pathology department. The OATS thanks the participants for their time and generosity in contributing to this research and acknowledges the contribution of the OATS research team (https://cheba.unsw.edu.au/project/older-australian-twins-study) to this study. The data analysed in this study are available in Gene Expression Omnibus (GSE56105, GSE105018, GSE61496, GSE100227, GSE73115) and ArrayExpress (E-MTAB-1866). The NTR correlation data is available in van Dongen et al (Ref. 13). The data of PETS and OATS are available from the relevant authors on request. Funding Information: This work was supported by grant ECRF19020 from the Victorian Cancer Agency, and by grant 1187896 awarded through the 2019 Priority-driven Collaborative Cancer Research Scheme and funded by Cure Cancer with the support of Cancer Australia. SL is a Victorian Cancer Agency Early Career Research Fellow (ECRF19020). SL and TLN were supported by the Cancer Council Victoria Postdoctoral Research Fellowship and the Picchi Award from the Victorian Comprehensive Cancer Centre. TLN was supported by the Cure Cancer Australia (APP1159399), and received a Grants-in-Aid grant from the Cancer Council Victoria (AF7305). MCS is a National Health and Medical Research Council (NHMRC) Senior Research Fellow (APP1155163). JLH is a NHMRC Senior Principal Research Fellow. The PETS was supported by grants from the NHMRC (Grant No. 1146333 to JC). The AMDTSS was facilitated through access to Twins Research Australia, a national resource supported by a Centre of Research Excellence Grant (Grant No. 1079102) from the NHMRC. The AMDTSS was supported by NHMRC (Grant Nos. 1050561 and 1079102), Cancer Australia and National Breast Cancer Foundation (Grant No. 509307). The OATS was funded by a NHMRC and Australian Research Council (ARC) Strategic Award Grant of the Ageing Well, Ageing Productively Program (Grant No. 401162) and NHMRC Project Grants (Grant Nos. 1045325 and 1085606). The OATS was facilitated through Twins Research Australia, a national resource in part supported by a Centre for Research Excellence Grant (Grant No. 1079102) from the NHMRC. Publisher Copyright: {\textcopyright} 2022 The Authors",
year = "2022",
month = mar,
doi = "10.1016/j.ebiom.2022.103927",
language = "English",
volume = "77",
journal = "EBioMedicine",
issn = "2352-3964",
publisher = "The Lancet Publishing Group",
}